The Journal of Organic Chemistry
Article
1
1.306 g, 97%). H NMR spectrum was in accordance with literature
data.
70.5, 34.9, 26.9, 15.0, 14.4; HRMS (ESI+) calcd for C14H18NO2
232.1338, found 232.1336.
2-Methyl-4-sec-butyl-5-ethoxy-1,3-oxazole 2c: 0.38 mmol, 69
mg, 42%; 100% CH2Cl2, Rf = 0.7; yellow oil; IR (neat) 2954, 2928,
1667, 1587, 1371, 1256, 1191, 1021; 1H (300 MHz, CDCl3) δ 4.10 (q,
J = 7.2 Hz, 2H), 2.31 (s, 3H), 2.20 (d, J = 6.9 Hz, 2H), 1.97−1.88 (m,
1H), 1.35 (t, J = 7.2 Hz, 2H), 0.91 (d, J = 4.2 Hz, 6H); 13C (75 MHz,
CDCl3) δ 154.2, 152.1, 116.0, 70.3, 33.7, 27.8, 22.4, 15.1, 14.3; HRMS
(ESI+) calcd for C10H18NO2 184.1338, found 184.1336.
Ethyl 2-(5-ethoxy-2-methyloxazol-4-yl)acetate 2d: 0.68
mmol, 144 mg, 75%; 80% cyclohexane/20% AcOEt, Rf = 0.1; yellow
oil; IR (neat) 2980, 1735, 1679, 1584, 1377, 1257, 1181, 1151, 1019;
1H (200 MHz, CDCl3) δ 4.23−4.11 (m, 4H), 3.40 (s, 2H), 2.33 (s,
Ethyl 4-Methyl-2-[[(trifluoromethyl)sulfonyl]oxy]pentanoate
1e. The triflate was prepared according to the procedure described
above using ethyl 2-hydroxy 4-methylpentanoate (600 mg, 3.75
mmol), 2,6-lutidine (0.52 mL, 4.50 mmol, 1.2 equiv) and
trifluoromethanesulfonic anhydride (0.69 mL, 4.13 mmol, 1.1 equiv)
in dry CH2Cl2 (3 mL). The crude product was purified by
chromatography on silica gel (100% CH2Cl2, Rf = 0.8) to give the
product as an orange oil (3.34 mmol, 976 mg, 89%): IR (neat) 2968,
1764, 1417, 1197, 1143; 1H (200 MHz, CDCl3) δ 5.17−5.11 (m, 1H),
4.30 (q, J = 7.2 Hz, 2H), 2.01−1.92 (m, 1H), 1.88−1.70 (m, 2H), 1.33
(t, J = 7.2 Hz, 3H), 0.99 (d, J = 6.0 Hz, 6H); 13C (75 MHz, CDCl3) δ
167.6, 118.6 (q, J = 317.3 Hz), 82.6, 62.7, 40.7, 24.1, 22.8, 21.0, 13.9.
Anal. Calcd for C9H15F3O5S: C, 36.98; H, 5.16; S, 10.97. Found: C,
36.97; H, 5.16; S, 10.79.
Diethyl 2-[[(Trifluoromethyl)sulfonyl]oxy]succinate 1f. The
triflate was prepared according to the procedure described above,
using the diethyl 2-hydroxysuccinate (500 mg, 2.63 mmol), 2,6-
lutidine (0.37 mL, 3.16 mmol, 1.2 equiv), and trifluoromethanesul-
fonic anhydride (0.49 mL, 2.89 mmol, 1.1 equiv) in dry CH2Cl2 (5
mL). The crude product was purified by chromatography on silica gel
(100% CH2Cl2, Rf = 0.8) to give the product as an orange oil (2.48
mmol, 800 mg, 95%): IR (neat) 2985, 1739, 1419, 1201, 1140, 1021;
1H (200 MHz, CDCl3) δ 5.48 (t, J = 5.8 Hz, 1H), 4.33 (q, J = 7.2 Hz,
3H), 1.36 (td, J = 7.2 Hz, J = 0.8 Hz, 3H), 1.26 (td, J = 7.2 Hz, J = 0.8
Hz, 3H); 13C (75 MHz, CDCl3) δ 170.4, 154.8, 152.4, 109.9, 70.3,
60.8, 30.7, 14.8, 14.2, 14.1; HRMS (ESI+) calcd for C10H16NO4
214.1079, found 214.1083.
2-(5-Ethoxy-2-methyloxazol-4-yl)ethyl methanesulfonate
2e: 0.38 mmol, 94 mg, 54%, 80% cyclohexane/20% AcOEt, Rf =
0.3; yellow oil; IR (neat) 2990, 2933, 1674, 1737, 1674, 1350, 1268,
1
1169; H (300 MHz, CDCl3) δ 4.41 (t, J = 6.9 Hz, 2H), 4.15 (q, J =
7.2 Hz, 2H), 2.98 (s, 3H), 2.81 (t, J = 6.9 Hz, 2H), 2.31 (s, 3H), 1.36
(t, J = 7.2 Hz, 3H); 13C (75 MHz, CDCl3) δ 154.7, 152.6, 111.0, 70.4,
68.1, 37.2, 25.0, 14.9, 14.2; HRMS (ESI+) calcd for C9H16NO5S
250.0749, found 250.0759.
3,4-Dimethyl-2(5H)-furanone 2f:26 0.77 mmol, 86 mg, 85%,
2H), 4.22 (q, J = 7.2 Hz, 2H), 3.04 (d, J = 6.0 Hz, 2H), 1.34 (t, J = 7.2
Hz, 3H), 1.28 (t, J = 7.2 Hz, 3H); 13C (75 MHz, CDCl3) δ 167.6,
166.1, 118.4 (q, J = 317.6 Hz), 78.9, 63.2, 61.8, 36.9, 14.0, 13.8; HRMS
(ESI+) calcd for C9H14F3O7S 323.0401, found 323.0407.
1
100% CH2Cl2, Rf = 0.2. H NMR spectrum is in accordance with
literature: 1H (200 MHz, CDCl3) δ 4.61 (q, J = 1.0 Hz, 2H), 2.01 (d, J
= 1.0 Hz, 3H), 1.81 (q, J = 1.0 Hz, 3H).
2-Methyl-4-phenyl-5-methoxy-1,3-oxazole 2g:10 0.69 mmol,
Ethyl 4-[(Methylsulfonyl)oxy]-2-[[(trifluoromethyl)sulfonyl]-
oxy]butanoate 1g. The triflate was prepared according to the
procedure described above, using ethyl 2-hydroxy 4-[(methylsulfonyl)-
oxy]butanoate25 (231 mg, 1.02 mmol, 1 equiv), 2,6-lutidine (0.12 mL,
1.22 mmol, 1.2 equiv), and trifluoromethanesulfonic anhydride (0.19
mL, 4.13 mmol, 1.12 equiv) in dry CH2Cl2 (4 mL). The crude product
was purified by chromatography on silica gel (100% CH2Cl2, Rf = 0.7)
to give the product as an orange oil (0.72 mmol, 257 mg, 70%): IR
(neat) 2987, 2951, 1754, 1413, 1360, 1205, 1174, 1138; 1H (200 MHz,
CDCl3) δ 5.29 (dd, J = 7.2 Hz, J = 4.6 Hz, 1H), 4.48−4.28 (m, 4H),
3.05 (s, 3H), 2.54−2.43 (m, 2H), 1.35 (t, J = 7.2 Hz, 3H); 13C (50
MHz, CDCl3) δ 166.3, 118.4 (q, J = 317.4 Hz), 79.5, 63.8, 63.1, 37.1,
31.5, 13.7; HRMS (ESI+) calcd for C8H13F3O8NaS2 380.9902, found
380.9906.
1
130 mg, 76%; yellow oil. H NMR spectrum is in accordance with
literature: 1H (200 MHz, CDCl3) δ 7.77 (d, J = 7.6 Hz, 2H), 7.37 (t, J
= 7.4 Hz, 2H), 7.21 (t, J = 7.4 Hz, 1H), 4.03 (s, 3H), 2.42 (s, 3H).
2-Methyl-4-phenyl-5-ethoxy-1,3-oxazole 2h:27 0.64 mmol,
1
129 mg, 70%; yellow oil. H NMR spectrum is in accordance with
literature: 1H (300 MHz, CDCl3) δ 7.79 (d, J = 7.2 Hz, 2H), 7.37 (t, J
= 7.5 Hz, 2H), 7.21 (t, J = 7.5 Hz, 1H), 4.30 (q, J = 7.2 Hz, 2H), 2.41
(s, 3H), 1.45 (t, J = 7.2 Hz, 3H).
2-Methyl-4-phenyl-5-n-propyloxy-1,3-oxazole 2i: 0.53 mmol,
1
114 mg, 58%; yellow oil; IR (neat) 2974, 1643, 1365, 1201; H (300
MHz, CDCl3) δ 7.79 (d, J = 8.4 Hz, 2H), 7.37 (t, J = 7.5 Hz, 2H), 7.20
(t, J = 7.2 Hz, 1H), 4.19 (t, J = 6.6 Hz, 2 Hz), 2.41 (s, 3H), 1.83 (hex, J
= 7.2 Hz, 2H), 1.05 (t, J = 7.2 Hz, 3H); 13C (75 MHz, CDCl3) δ
153.6, 151.7, 131.4, 128.2, 125.9, 124.6, 114.7, 75.1, 22.6, 14.0, 10.1;
HRMS (ESI+) calcd for C13H16NO2 218.1176, found 218.1175.
2-Benzyl-4-methyl-5-ethoxy-1,3-oxazole 2j: 0.45 mmol, 98
mg, 50%, 100% CH2Cl2, Rf = 0.4; yellow oil; IR (neat) 2984, 2937,
1661, 1322, 1234, 1015; 1H (300 MHz, CDCl3) δ 7.34−7.21 (m, 5H),
4.08 (q, J = 7.1 Hz, 2H), 3.94 (s, 2H), 2.00 (s, 3H), 1.31 (t, J = 7.1 Hz,
3H); 13C (75 MHz, CDCl3) δ 153.9, 153.6, 135.8, 128.6, 128.6, 126.9,
112.7, 70.2, 35.1, 14.9, 10.0; HRMS (ESI+) calcd for C13H16NO2
218.1181, found 218.1180.
General Procedure for the Synthesis of the 5-Alkoxyox-
azoles 2a−r. To the corresponding triflate (0.9 mmol) was added
acetonitrile (2.40 mL) or a functionalized nitrile (4.5 mmol, 5 equiv)
under inert atmosphere in a microwave vial, equipped with a magnetic
stirrer bar. Then, trimethylsilyl trifluoromethanesulfonate (16 μL, 0.09
mmol, 0.1 equiv) was added. The vial was sealed and the reaction was
performed in a microwave during 3 min (holding time) at 120 °C with
a maximum power of 100 W. The solution was quenched with satd aq
NaHCO3 (10 mL) and extracted with CH2Cl2 or AcOEt (2 × 15 mL).
The organic phases were washed with brine (5 mL), dried over
MgSO4, and concentrated under reduced pressure. The crude product
was finally purified by chromatography on silica gel to give the desired
product. For aromatic α-hydroxy esters (0.9 mmol), the same
procedure was used. However, the quantity of trimethylsilyl
trifluoromethanesulfonate was increased (0.29 mL, 1.58 mmol, 1.75
equiv).
2-n-Propyl-4-methyl-5-ethoxy-1,3-oxazole 2k: 0.52 mmol, 88
mg, 58%, 100% CH2Cl2, Rf = 0.2; yellow oil; IR (neat) 2965, 1741,
1
1675, 1576, 1223; H (300 MHz, CDCl3) δ 4.10 (q, J = 7.2 Hz, 2H),
2.57 (t, J = 7.5 Hz, 2H), 2.00 (s, 3H), 1.71 (quint, J = 7.5 Hz, 2H),
1.34 (t, J = 7.2 Hz, 3H), 0.97 (t, J = 7.5 Hz, 2H); 13C (75 MHz,
CDCl3) δ 155.4, 153.2, 112.1, 70.0, 30.2, 20.1, 14.7, 13.4, 9.7; HRMS
(ESI+) calcd for C9H16NO2 170.1181, found 170.1175.
2-Ethyl-4-phenyl-5-ethoxy-1,3-oxazole 2l: 0.58 mmol, 134 mg,
2,4-Dimethyl-5-ethoxy-1,3-oxazole 2a:1b 0.57 mmol, 80 mg,
1
64%; yellow oil; IR (neat) 2969, 1741, 1642, 1449, 1361; H (300
1
1
63%. H NMR spectrum is in accordance with literature: H (200
MHz, CDCl3) δ 4.10 (q, J = 7.0 Hz, 2H), 2.30 (s, 3H), 1.99 (s, 3H),
1.34 (t, J = 7.0 Hz, 3H).
MHz, CDCl3) δ 7.80 (d, J = 7.2 Hz, 2H), 7.37 (t, J = 7.5 Hz, 2H), 7.20
(t, J = 7.2 Hz, 1H), 4.20 (t, J = 6.6 Hz, 2H), 2.74 (q, J = 7.5 Hz, 2H),
1.83 (m, J = 7.5 Hz, 2H), 1.34 (t, J = 7.8 Hz, 3H), 1.05 (t, J = 7.2 Hz,
3H); 13C (75 MHz, CDCl3) δ 156.1, 153.5, 131.6, 128.3, 125.9, 124.7,
114.6, 75.0, 22.7, 21.9, 11.1, 10.2; HRMS (ESI+) calcd for C14H18NO2
232.1338, found: 232.1330.
2-n-Propyl-4-phenyl-5-ethoxy-1,3-oxazole 2m: 0.51 mmol,
118 mg, 57%; yellow oil; IR (neat) 2968, 1642, 1604, 1449, 1379,
1352, 1192; 1H (300 MHz, CDCl3) δ 7.81 (d, J = 7.2 Hz, 2H), 7.37 (t,
5-Ethoxy-2-methyl-4-phenethyl-1,3-oxazole 2b: 0.56 mmol,
130 mg, 63%; 100% CH2Cl2, Rf = 0.1; yellow oil; IR (neat) 3029,
2975, 2929, 1667, 1583, 1452, 1378, 1267, 1016; 1H (200 MHz,
CDCl3) δ 7.31−7.17 (m, 5H), 3.87 (q, J = 7.0 Hz, 2H), 2.94−2.87 (m,
2H), 2.68−2.60 (m, 2H), 2.34 (s, 3H), 1.24 (t, J = 7.0 Hz, 3H); 13C
(75 MHz, CDCl3) δ 153.9, 152.4, 141.9, 128.6, 128.3, 125.9, 116.1,
8553
dx.doi.org/10.1021/jo301527t | J. Org. Chem. 2012, 77, 8549−8555